Immunodeficiency common variable and Blushing
Summary:
Blushing is found among people with Immunodeficiency common variable, especially for people who are female, 60+ old.
The study analyzes which people have Blushing with Immunodeficiency common variable. It is created by eHealthMe based on reports of 220 people who have Immunodeficiency common variable from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Immunodeficiency common variable?
Immunodeficiency common variable is found to be associated with 87 drugs and 143 conditions by eHealthMe. Check the latest studies of Immunodeficiency common variable.
What is Blushing?
Blushing is found to be associated with 3,221 drugs and 2,919 conditions by eHealthMe. Check the latest studies of Blushing.
220 people who have Immunodeficiency Common Variable and Blushing are studied.

Gender of people who have Immunodeficiency Common Variable and experienced Blushing *:
- female: 75.7 %
- male: 24.3 %
Age of people who have Immunodeficiency Common Variable and experienced Blushing *:
- 0-1: 0.0 %
- 2-9: 9.76 %
- 10-19: 5.69 %
- 20-29: 8.94 %
- 30-39: 8.94 %
- 40-49: 10.57 %
- 50-59: 21.95 %
- 60+: 34.15 %
Common co-existing conditions for these people *:
- Primary Immunodeficiency Syndrome: 31 people, 14.09%
- Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 6 people, 2.73%
- Burkitt Lymphoma (cancer of the lymphatic system): 5 people, 2.27%
- Asthma: 4 people, 1.82%
- Amyloidosis Senile (common form of amyloidosis in very old people, usually mild and limited to the heart): 4 people, 1.82%
- Hypergammaglobulinaemia (elevated levels of gamma globulin): 3 people, 1.36%
- Joint Pain: 2 people, 0.91%
- Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 0.91%
- Abdominal Discomfort: 2 people, 0.91%
- Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 2 people, 0.91%
Common drugs taken by these people *:
- Acetaminophen: 59 people, 26.82%
- Epinephrine: 56 people, 25.45%
- Hizentra: 48 people, 21.82%
- Sodium Chloride: 45 people, 20.45%
- Singulair: 38 people, 17.27%
- Vitamin D3: 37 people, 16.82%
- Lidocaine: 33 people, 15.00%
- Benadryl: 32 people, 14.55%
- Tylenol: 32 people, 14.55%
- Albuterol Sulfate: 28 people, 12.73%
Common symptoms for these people *:
- Fatigue (feeling of tiredness): 73 people, 33.18%
- Headache (pain in head): 59 people, 26.82%
- Nausea (feeling of having an urge to vomit): 51 people, 23.18%
- Rashes (redness): 48 people, 21.82%
- Infusion Related Reaction: 42 people, 19.09%
- Dizziness: 40 people, 18.18%
- Dyspnea (difficult or laboured breathing): 37 people, 16.82%
- Diarrhea: 34 people, 15.45%
- Chills (felling of cold): 34 people, 15.45%
- Chest Pain: 33 people, 15.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Blushing?
- Check whether Blushing is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Immunodeficiency common variable (31,613 reports)
- Blushing (117,676 reports)
All the drugs that are associated with Blushing:
- Blushing (3,221 drugs)
All the conditions that are associated with Blushing:
- Blushing (2,919 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Blushing and Immunodeficiency common variable, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Kenalog and Neulasta - 2 seconds ago
- Could Escitalopram cause Peripheral Sensorimotor Neuropathy? - 6 seconds ago
- Remicade and Hair Loss for Women aged 20-29 - 7 seconds ago
- Remicade and Hair Thinning for Women aged 20-29 - 7 seconds ago
- Remicade and Hairloss for Women aged 20-29 - 7 seconds ago
- Remicade and Baldness for Women aged 20-29 - 7 seconds ago
- Remicade and Alopecia for Women aged 20-29 - 8 seconds ago
- Remicade and Loss Of Hair for Women aged 20-29 - 8 seconds ago
- Could Olanzapine cause Nuchal Rigidity? - 9 seconds ago
- Back Pain Aggravated and Musculoskeletal Stiffness - 24 seconds ago